NGEN

NASDAQ · Equity

NervGen Pharma Corp.

US Healthcare Biotechnology

Latest week
29 May 2026
Close
2.070000
Fair value
3.896250
Expectation
Negative 35.15%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
2.07
12-Week Change
-42.50%
Trend Signal
Inactive
Expectation
Negative 35.15%
Signal Weeks
0 of 12
Vs Fair Value
Below
Market Dynamics
0.00

Over the latest 12 completed weeks ending 2026-05-29, NGEN fell 42.50%, moving from 3.60 to 2.07. The latest weekly close is below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Market Dynamics is 0.00 on the latest week. Expectation is negative at 35.15%.